Sun. Jan 17th, 2021

Objective: detect early stage tumors with a blood test. Juan Martínez-Barea is the founder of Universal DX, a biomedical company that develops a test for the early detection of cancer

His words captivate. It speaks of drones flying over agricultural fields in search of data, of the digital struggle between the great powers of the world and of the artificial intelligence that will be in schools.

But what most captivates the founder of Universal DX, Juan Martínez-Barea, is his passion for the technological application to biological systems. “The more I know about biotechnology, the more our DNA amazes me,” says the author of The Coming World.

It is no coincidence that it is his favorite subject. His startup has been dedicated in the last six years to the study of the smallest molecules that circulate in our blood and that change when cancer begins to be triggered.

The goal is to detect the disease very early through a test. To achieve this they use massive data analysis. The advance is the result of years of work. The health sector has been at the top of the digital wave for some time, and has allowed the development of new treatments and medicines at unprecedented speed, such as the new vaccine against the pandemic.

“There is even talk of organ printing,” he says in a conversation with specialists at SAS, the advanced analytics and artificial intelligence software firm . That technological leadership in medicine, and in other industries, is outside Europe. The United States and China take the lead, while the Old Continent is a mere spectator.

“Europe is not clear on it. We are always focused on problems that are not the real ones in this world to come, “argued Martínez-Barea, who has been an ambassador for Singularity University, an academic institution sponsored by Google and NASA, and based in Silicon Valley.

One of the big problems is that European investors are much more traditional. “They risk less, with which we are at a very clear disadvantage against the great powers.” In Spain, the situation is no different: “There is a lack of startups of a true level”.

Martínez-Barea also talks about why Chinese startups have been forged in the worst of the world’s markets, about the pessimism that reigns in the Spanish innovative sector and how new technologies are going to flood the entire economy. “All sectors are going to be high-tech,” he says.

Do Extraordinary Things is a project of SAS, the advanced analytics and artificial intelligence software firm. During the pandemic, SAS has created a content space for all those who believe that data can change the world, help us emerge from crisis situations and prosper as individuals and society.

4Leaders is a space for conversation in Do Extraordinary Things, where opinion leaders and experts share messages of optimism and resilience to overcome the impact of covid-19.

Leave a Reply

Your email address will not be published. Required fields are marked *